Profilo
Patrick Chaltin is currently Director at Cytura Therapeutics BV and Managing Partner at Centre for Drug Design & Discovery.
Formerly, Dr. Chaltin was Non-Executive Director at Aratana Therapeutics NV.
Dr. Chaltin earned a doctorate from Katholieke Universiteit Leuven.
Posizioni attive di Patrick Chaltin
| Società | Posizione | Inizio |
|---|---|---|
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Direttore/Membro del Consiglio | - |
Centre for Drug Design & Discovery
Centre for Drug Design & Discovery Investment ManagersFinance Centre for Drug Design & Discovery is an active manager which invests in companies located in Belgium. It participates in seed stage and early stage transactions and focuses on the Health Technology sector. | Investitore di Private Equity | - |
Precedenti posizioni note di Patrick Chaltin
| Società | Posizione | Fine |
|---|---|---|
Aratana Therapeutics NV
Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Develops and markets drugs to treat viral infections in both pet animals and livestock | Direttore/Membro del Consiglio | - |
Formazione di Patrick Chaltin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aratana Therapeutics NV
Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Develops and markets drugs to treat viral infections in both pet animals and livestock | Health Technology |
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Centre for Drug Design & Discovery
Centre for Drug Design & Discovery Investment ManagersFinance Centre for Drug Design & Discovery is an active manager which invests in companies located in Belgium. It participates in seed stage and early stage transactions and focuses on the Health Technology sector. | Finance |
















